The range of neurological defect as NIHSS evaluate was the widest.
NIHSS评定的神经功能缺损范围最大。
All patients were marked by score of The National Institutes of Health Stroke Scale (NIHSS).
采用美国国立卫生研究院卒中量表(NIHSS)对所有患者进行神经功能评分。
Use of the baseline NIHSS score to predict stroke outcome must take hemispheric lateralization into account.
使用NIHSS基础分数预测卒中预后必须将半球因素考虑在内。
NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.
在两个试验中，在组织纤维蛋白溶酶原激活剂使用前，都先用NIHSS评分。
CONCLUSIONS: Relative changes in serial NIHSS scores can serve as a simple clinical indicator of arterial status after intravenous thrombolysis.
结论∶一系列NIHSS记分的相对变化可以充当一个单纯的临床指标，反映静脉内溶栓后动脉的情况。
Conclusions - Relative changes in serial NIHSS scores can serve as a simple clinical indicator of arterial status after intravenous thrombolysis.
结论——在一些列nihss评分中的相应改变可以作为经静脉注射血栓溶解剂后一个简单的血管状态的临床指示器。
The release of MBP in patients was associated with the volume of brain lesions (P<0.01) and the neurological outcome as assessed by NIHSS (P<0.01).
MBP的血浆浓度与梗死体积呈显著正相关（P<0.01），与神经功能缺损程度也呈显著正相关（P<0.01）。
Compared with small - vessel occlusion subtypes, NIHSS score increased significantly in cardioembolism and large - artery atherosclerosis patients ( P < 0. 01 ).
与小动脉闭塞型比较，心源性栓塞型、大动脉粥样硬化型NIHSS评分差异有统计学意义（P〈0．01）。
The NIHSS and BMD of the group treated by rehabilitation training in the early stage combined with calcium supplementation were significantly different (P<0.001).
试验组的骨密度水平和神经功能缺损治疗前后比较差异均有非常显著性（P<0.001）。
Methods the neural function of primary cerebral infarction patients was studied by the National Institutes of Health Stroke Scale (NIHSS) with rank test and multiple regression analysis.
方法采用美国国立卫生院卒中量表(NIHSS)对初发脑梗死患者神经功能进行评价研究，运用秩和检验和多元逐步回归的方法进行统计分析。
Where ischemic penumbra existed, the intra-arterial thrombolysis was administered. It was assessed by NIHSS score before and after thrombolytic therapy at the 3rd week and the 3rd month.
对存在缺血半暗带患者给予动脉溶栓治疗，并分别于溶栓前、溶栓后即刻、溶栓后3周和3个月进行NIHSS评分，以评估近期及远期疗效。
Before discharge, three months after treatment, six months, one year after the ultrasound follow-up significant changes in plaque thickness, and was closely related with the change in NIHSS score.
出院前、治疗后3个月、半年、一年后彩超随访斑块厚度有明显变化，且与NIHSS评分变化有密切关系。
Before discharge, three months after treatment, six months, one year after the ultrasound follow-up significant changes in plaque thickness, and was closely related with the change in NIHSS score.
出院前、治疗后3个月、半年、一年后彩超随访斑块厚度有明显变化，且与NIHSS评分变化有密切关系。
应用推荐